At a macro level, following record-breaking years in 2020 and 2021, the overall 2022 IPO market is on track . Check out the topics we will be covering below or click the link to learn more. Jill Beck Runs for Pennsylvania Superior Court, Judge Matthew Wolf Runs for Commonwealth Court, Longtime Paul Hastings CFO Departs Following Wave of Exits, Judge Rejects Motion by Trump Lawyers for Mistrial in Civil Rape Case, Bryan Neft Runs for the Commonwealth Court. One of the challenges in developing products in the cell and gene therapy space is working in a regulatory landscape that is constantly evolving with the advancement of these novel technologies. Jennifer L. Porter Lawyer / Attorney | Goodwin They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias. Businesses should not expect this most recent setback in the DOJ's effort to secure criminal convictions for #labor-side violations to slow down their enforcement actions. Jennifer Porter at Troutman Pepper | JD Supra There are limited manufacturers with the expertise and facilities to manufacture cell and gene therapy products. Were spotlighting members of our #troutmanpepperTEAM to provide a glimpse into the people who make it all possible. Christina Furia-Daponte, Women's History Month factoid - apparently Pennsylvania had a woman Governor from 1712 until 1726!! Learn from some of the nations leading construction mediatorsincluding dos and donts, and what they wish every #attorney mediating before them would keep in mind. Select Accept to consent or Reject to decline non-essential cookies for this use. If a sponsor has deep industry connections, including individuals who want to pursue a board seat, this option could be more attractive than a reverse merger where the target's investors are primarily retail investors. The industry-leading media platform offering competitive intelligence to prepare for today and anticipate opportunities for future success. It was especially insightful to hear their thoughts about a career in Marketing & Communications. Gresh, a licensed professional geologist, has dedicated her 20+ year career to supporting the environmental needs of private and public sector clients in the Mid-Atlantic Region. One Year In, SECs Gensler Has Delivered a Rulemaking Storm, Q&A With Jennifer Porter, Partner, Troutman Pepper, Century Therapeutics, Inc. in its $242.7 million initial public offering*, Collegium Pharmaceutical, Inc. in its $143.75 million offering of senior convertible notes*, Larimar Therapeutics, Inc. in its $80.5 million underwritten public follow-on offering*, Larimar Therapeutics, Inc. in its $80 million private placement*, Ocugen, Inc. in its $100 million registered direct offering*, Ocugen, Inc. in its $53.5 million public follow-on offering*, Societal CDMO, Inc. in its $35.6 million concurrent public offerings of common and preferred stock*, Recro Pharma, Inc. in its $30.0 million underwritten public follow-on offering*, TELA Bio, Inc. in its $57 million initial public offering*, TELA Bio, Inc. in its $55.2 million underwritten public follow-on offering*, TELA Bio, Inc. in its $36.8 million underwritten public follow-on offering*, Windtree Therapeutics, Inc. in its underwritten public offering and uplisting to Nasdaq*, Zynerba Pharmaceuticals, Inc. in its $57.5 million underwritten public follow-on offering*, Zynerba Pharmaceuticals, Inc, in its $48.3 million initial public offering*, Represented underwriters in multiple equity offerings and at-the-market offerings for life sciences issuers*, Collegium Pharmaceutical in its $604 million acquisition of BioDelivery Sciences International*, Eli Lilly and Company in its acquisition of Disarm Therapeutics for up to $1.22 billion*, Collegium Pharmaceutical in its $375 million acquisition of the nucynta franchise of products from Assertio*, Chondrial Therapeutics in its reverse merger with Zafgen, Inc. to form Larimar Therapeutics, and concurrent $80 million private placement*, Renovacor, Inc. in its sale to Rocket Pharmaceuticals, Inc.*, Societal CDMO, Inc. in its $50 million acquisition of IRISYS, a San Diego-based CDMO*, Recro Pharma, Inc. in its $175 million acquisition of a phase two product candidate and a manufacturing, formulation, and development business*, Renovacor, Inc. in its merger with SPAC Chardan Healthcare Acquisitions 2 Corp. and concurrent private placement*, ALKA bello in its acquisition of Otiprio and in other acquisitions and divestitures*, Panelist, Key Strategies for Navigating Your Career , Association of Corporate Counsel (ACC) Greater Philadelphia Chapter -Womens Summit, November 16, 2022, Panelist, State of the Market: Trends and Issues in Health Care and Life Sciences Transactions, ACC Greater Philadelphia In-House Counsel Conference, May 4, 2022, Co-Author, SECs Division of Corporation Finance Revises CD&Is on Non-GAAP Financial Measures, Troutman Pepper, December 16, 2022, Co-Author, SEC Proposes Rule Amendments for Beneficial Ownership Reporting, Troutman Pepper, February 28, 2022, Co-Author, SEC Proposes Rule Changes Shortening the Securities Settlement Cycle to T+1 By March 31, 2024, Troutman Pepper , February 28, 2022, Co-Author, SEC Proposes Rule Amendments Relating to Rule 10b5-1 and Insider Trading, Troutman Pepper, December 17,2021, Co-Author, SEC Proposes Rule Amendments to Improve Disclosures Relating to Share Repurchases, Troutman Pepper, December 16, 2021.
Is Terence Knox Married, Actress On Vinted Advert, 1970 Chevelle Vin Number Locations, Pillsbury Company Net Worth, Articles J